Commentary - (2025) Volume 17, Issue 4
Received: 01-Jul-2025, Manuscript No. jcst-25-174951;
Editor assigned: 03-Jul-2025, Pre QC No. P-174951;
Reviewed: 17-Jul-2025, QC No. Q-174951;
Revised: 22-Jul-2025, Manuscript No. R-174951;
Published:
29-Jul-2025
, DOI: 10.37421/1948-5956.2025.17.714
Citation: Andersen, Mia. ”Nanoparticles: Revolutionizing
Medicine Across Diverse Applications.” J Cancer Sci Ther 17 (2025):714.
Copyright: © 2025 Andersen M. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use,
distribution and reproduction in any medium, provided the original author and source are credited.
Nanoparticle-based photothermal therapy (PTT) represents a highly promising and rapidly evolving strategy for effective cancer treatment. Research in this domain extensively reviews current advancements in designing innovative nanomaterials specifically for PTT applications, thoroughly discussing their diverse mechanisms of action and inherent advantages. Crucially, these studies also confront persistent challenges such as achieving optimal biocompatibility, enhancing targeting efficiency, and navigating the complexities of clinical translation [1].
Addressing the critical global challenge of antibiotic resistance, nanoparticle-based approaches present groundbreaking solutions for managing bacterial infections. Detailed reviews explore a wide array of nanoparticle types, encompassing metallic, polymeric, and lipid-based systems. They meticulously explain their multifaceted mechanisms, which include targeted antimicrobial delivery, direct disruption of bacterial membranes, and potentiation of host immune responses against pathogens [2].
The therapeutic application of nanoparticles in gene therapy for complex neurological disorders holds immense potential, primarily by effectively circumventing significant delivery barriers within the central nervous system. This area of research investigates various sophisticated nanoparticle platforms, elucidating their ingenious strategies for encapsulating and precisely delivering genetic material. The therapeutic implications for debilitating conditions like Alzheimer's, Parkinson's, and Huntington's diseases are particularly emphasized [3].
Engineered nanoparticles are proving indispensable in accelerating progress in cancer immunotherapy, markedly enhancing the targeted delivery and overall efficacy of vital immunomodulatory agents. Comprehensive reviews outline how these precisely engineered nanoparticles can significantly improve antigen presentation, boost T cell activation, and enable more effective immune checkpoint blockade, thereby overcoming current limitations associated with conventional immunotherapies and considerably expanding therapeutic windows [4].
Nanoparticle-based strategies are fundamentally vital for actualizing the full promise of precision medicine, facilitating highly targeted drug delivery, sophisticated diagnostics, and advanced theranostics. Thorough reviews in this field delve into the fundamental design principles of diverse nanocarriers engineered for personalized therapies, highlighting their instrumental role in interacting with specific disease biomarkers, drastically minimizing undesirable systemic side effects, and ultimately improving crucial patient outcomes [5].
Revolutionizing regenerative medicine, nanoparticle technology offers cutting-edge tools essential for robust tissue repair and complex organ regeneration. This scientific domain explores the multifaceted ways nanoparticles can efficiently deliver critical growth factors, stem cells, and genetic material. Furthermore, they can finely modulate cellular microenvironments and significantly enhance therapeutic efficacy across a broad spectrum of applications, ranging from intricate bone repair to delicate nerve regeneration processes [6].
Strategic nanoparticle-based drug delivery systems confer a distinct advantage in antiviral therapy by substantially improving drug bioavailability, precisely targeting infected cells, and effectively reducing systemic toxicity. Relevant research discusses a variety of innovative nanocarrier platforms designed for the effective delivery of antiviral agents, including small molecules, therapeutic peptides, and nucleic acids, against a wide array of viral infections [7].
Emerging as highly promising interventions, nanoparticle-based approaches are making significant strides in both the diagnosis and treatment of atherosclerosis, a prevalent and serious cardiovascular disease. Detailed articles investigate how specifically targeted nanoparticles can deliver potent anti-inflammatory, antioxidant, and anti-proliferative drugs directly to atherosclerotic plaques, thereby providing more effective and localized therapeutic alternatives compared to conventional treatment methodologies [8].
Nanoparticle-mediated therapies are rapidly establishing themselves as highly effective strategies for the comprehensive management of chronic inflammatory diseases. This area of study highlights how various nanocarriers can selectively and efficiently deliver anti-inflammatory agents to inflamed tissues, leading to a substantial minimization of systemic side effects and a considerable improvement in overall therapeutic efficacy in conditions such as rheumatoid arthritis, inflammatory bowel disease, and psoriasis [9].
In the challenging realm of brain tumor therapy, nanoparticle-based strategies offer truly innovative solutions for overcoming the formidable blood-brain barrier and significantly enhancing targeted drug delivery to brain malignancies. Key articles emphasize different types of nanocarriers, their crucial surface modifications designed for precise delivery, and their diverse applications across chemotherapy, gene therapy, photodynamic therapy, and immunotherapy for these aggressive brain cancers [10].
Nanoparticle-based approaches are rapidly transforming medical science, offering unprecedented opportunities for targeted therapies and diagnostics. In cancer treatment, nanoparticle-based photothermal therapy (PTT) has emerged as a promising strategy, with recent progress focusing on novel nanomaterials and their mechanisms to address challenges like biocompatibility and targeting efficiency [1]. Similarly, engineered nanoparticles are proving invaluable in advancing cancer immunotherapy, improving delivery and efficacy of immunomodulatory agents to enhance T cell activation and expand therapeutic windows [4]. These innovations aim to overcome limitations of conventional cancer treatments.
Beyond oncology, nanoparticles offer crucial solutions for combating infectious diseases. For bacterial infections, especially with antibiotic resistance, various metallic, polymeric, and lipid-based nanoparticles are explored for delivering antimicrobials, disrupting bacterial membranes, or enhancing host immunity [2]. Concurrently, in antiviral therapy, nanoparticle-based drug delivery systems strategically improve drug bioavailability, target infected cells, and reduce systemic toxicity, facilitating delivery of antiviral agents against a range of viral threats [7].
The therapeutic application of nanoparticles also extends to gene therapy for complex neurological disorders. These systems hold promise by overcoming delivery barriers to the central nervous system, exploring platforms for encapsulating and delivering genetic material for conditions like Alzheimer's, Parkinson's, and Huntington's diseases [3]. Furthermore, nanoparticle-based strategies are crucial for realizing precision medicine, enabling targeted drug delivery, diagnostics, and theranostics tailored to specific disease biomarkers, thereby minimizing side effects and improving patient outcomes [5].
Nanoparticle technology is revolutionizing regenerative medicine, providing advanced tools for tissue repair and organ regeneration. These nanoparticles can deliver growth factors, stem cells, and genetic material, modulating cellular microenvironments to enhance therapeutic outcomes in diverse applications such as bone and nerve regeneration [6]. Moreover, in managing chronic inflammatory diseases, nanoparticle-mediated therapies selectively deliver anti-inflammatory agents to inflamed tissues, improving efficacy and reducing systemic toxicity in conditions like rheumatoid arthritis, inflammatory bowel disease, and psoriasis [9].
Finally, significant strides are being made in cardiovascular health and brain malignancies. Nanoparticle-based interventions show great promise for the diagnosis and treatment of atherosclerosis, where targeted nanoparticles deliver anti-inflammatory, antioxidant, and anti-proliferative drugs directly to atherosclerotic plaques, offering more effective and localized therapeutic options [8]. Similarly, for brain tumors, nanoparticle-based strategies provide innovative solutions to overcome the blood-brain barrier. They enhance drug delivery through various nanocarriers and surface modifications, supporting applications in chemotherapy, gene therapy, photodynamic therapy, and immunotherapy for these aggressive cancers [10].
Nanoparticle-based strategies are revolutionizing medicine by offering advanced solutions across various therapeutic and diagnostic applications. These tiny carriers enhance drug delivery, overcome biological barriers, and improve treatment efficacy while minimizing side effects. For instance, in cancer treatment, nanoparticles are crucial for photothermal therapy (PTT), enhancing targeting efficiency and addressing challenges like biocompatibility [1]. They also advance cancer immunotherapy by improving the delivery and effectiveness of immunomodulatory agents, thereby expanding therapeutic windows [4]. Beyond oncology, nanoparticles provide novel solutions for combating bacterial infections by delivering antimicrobials or disrupting bacterial membranes, which is particularly important in the era of antibiotic resistance [2]. Their application in gene therapy shows significant promise for neurological disorders like Alzheimer's and Parkinson's, overcoming delivery hurdles to the central nervous system [3]. Precision medicine greatly benefits from nanoparticle-based strategies, enabling targeted drug delivery and theranostics tailored to specific disease biomarkers [5]. In regenerative medicine, nanoparticles serve as advanced tools for tissue repair and organ regeneration, delivering growth factors, stem cells, and genetic material [6]. They are also invaluable in antiviral therapy, improving drug bioavailability and targeting infected cells [7]. Furthermore, nanoparticles are proving effective in diagnosing and treating cardiovascular diseases like atherosclerosis by delivering targeted drugs to plaques [8]. They offer improved management for chronic inflammatory conditions such as rheumatoid arthritis, delivering anti-inflammatory agents to inflamed tissues with reduced systemic side effects [9]. Finally, nanoparticles offer innovative solutions for brain tumor therapy, overcoming the blood-brain barrier and enhancing targeted delivery for various treatment modalities [10]. This broad utility underscores their transformative impact on healthcare.
Indexed at, Google Scholar, Crossref
Indexed at, Google Scholar, Crossref
Indexed at, Google Scholar, Crossref
Indexed at, Google Scholar, Crossref
Indexed at, Google Scholar, Crossref
Indexed at, Google Scholar, Crossref
Indexed at, Google Scholar, Crossref
Indexed at, Google Scholar, Crossref
Indexed at, Google Scholar, Crossref
Cancer Science & Therapy received 5332 citations as per Google Scholar report
